FCHSD2-ABL1 Fusion FISH Probe
The FCHSD2-ABL1 Fusion FISH Probe is used to confirm a fusion of the FCHSD2 and ABL1 genes. The fusion of the FCHSD2 and ABL1 genes has been associated with Uterine Carcinosarcoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| FCHSD2-ABL1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| FCHSD2-ABL1-20-AQAQ | 20 (40 μL) | 200 μL |
|
ABL1 Gene Summary
This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons. [provided by RefSeq, Aug 2014]
Gene Name: ABL Proto-oncogene 1, Non-receptor Tyrosine Kinase
Chromosome: CHR9: 133589267 -133763062
Locus: 9q34.12
FCHSD2 Gene Summary
The FCH And Double SH3 Domains 2 (FCHSD2) gene is located on chr11 :72547789-72853143 at 11q13.4.
Gene Name: FCH And Double SH3 Domains 2
Chromosome: CHR11: 72547789 -72853143
Locus: 11q13.4
Gene Diseases
The FCHSD2 ABL1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Uterine Carcinosarcoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|